Analysis of a teaching case of severe acute pancreatitis treated by glucocorticoids

Published on Jan. 26, 2025Total Views: 113 times Total Downloads: 23 times Download Mobile

Affiliation: 1. Department of Pharmacy, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China 2. Department of Hepatobiliary Surgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China

Keywords: Severe acute pancreatitis Glucocorticoids Rational drug use Case analysis Teaching practice

DOI: 10.12173/j.issn.2097-4922.202410005

Reference: ZHOU Shiyi, CHENG Yao. Analysis of a teaching case of severe acute pancreatitis treated by glucocorticoids[J]. Yaoxue QianYan Zazhi, 2025, 29(1): 176-180. DOI: 10.12173/j.issn.2097-4922.202410005.[Article in Chinese]  Copied

Abstract
Full-text
References

Abstract

This paper reports a patient with severe acute pancreatitis treated by glucocorticoids. Glucocorticoids have strong anti-inflammatory effects and many adverse reactions. In order to improve the patient's condition and prognosis effectively, standardized clinical pharmacist trainees should actively participate in the treatment of severe acute pancreatitis, analyze the rational use of glucocorticoids, and treat severe acute pancreatitis through the prudent use of glucocorticoids. By strengthening multidisciplinary collaborations and adopting individualized treatment plans, the medication safety of the patients can be ensured. All of these will provide a reference for rational drug use for medical staff in clinical practice.

Full-text

Please download the PDF version to read the full text: download

References

1.中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南[J]. 浙江实用医学, 2021, 26(6): 511-519. DOI: 10.16794/j.cnki.cn33-1207/r.2021.06.003.

2.胡赞群. 糖皮质激素早期治疗重症急性胰腺炎合并器官损伤的临床疗效[D]. 南昌: 南昌大学, 2023. DOI: 10.27232/d.cnki.gnchu.2023.000813.

3.潘静, 徐晨阳, 宋嗣恩, 等. 糖皮质激素治疗重症急性胰腺炎的研究进展[J]. 医学综述, 2019 , 25(1): 82-86. [Pan J, Xu CY, Song SE, et al. Research Progress in Glucocorticoid Treatment for Severe Acute Pancreatitis[J]. Medical Recapitulate, 2019, 25(1): 82-86.] DOI: 10.3969/j.issn.1006-2084.2019.01.016.

4.Zhang J, Ge P, Liu J, et al. Glucocorticoid treatment in acute respiratory distress syndrome: an overview on mechanistic insights and clinical benefit[J]. Int J Mol Sci, 2023, 24(15): 12138-12172. DOI: 10.3390/ijms241512138.

5.Yahiaoui N, Roche M, Aissaoui-Hofmann N, et al. Intravenous methylprednisolone induced acute pancreatitis[J]. Eur J Clin Pharmacol, 2017, 73(5): 645-646. DOI: 10.1007/s00228-017-2207-5.

6.Wolfe D, Kanji S, Yazdi F, et al. Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations[J]. PLoS One, 2020, 15(4): e0231883. DOI: 10.1371/journal.pone.0231883.

7.Julve P, Garcia E, Catala B, et al. Acute pancreatitis as an effect of IV methylprednisolone in the treatment of optical neuritis[J]. Neurol Barc Spain, 1998, 13(7): 372-373. https://pubmed.ncbi.nlm.nih.gov/9810805/.

8.Sabre A, Guthrie MM, Maleknia R. Acute necrotising pancreatitis derived from low-dose corticosteroid use: an important reminder of clinical management[J]. BMJ Case Rep, 2015, 6(1): 1-4. DOI: 10.1136/bcr-2015-209325.

9.Yoshizawa Y, Ogasa S, Izaki S, et al. Corticosteroid-induced pancreatitis in patients with auto-immune bullous disease: Case report and prospective study[J]. Dermatol Basel Switz, 1999, 198(3): 304-306. DOI: 10.1159/000018137.

10.Bar S, Daudel F, Zueger T. Ominous triad triggered by high-dose glucocorticosteroid therapy[J]. BMJ Case Rep, 2017, 18(1): 1-4. DOI: 10.1136/bcr-2017-220328.

11.Nango D, Nakashima H, Hirose Y, et al. Causal relationship between acute pancreatitis and methylprednisolone pulse therapy for fulminant autoimmune hepatitis: a case report and review of literature[J]. J Pharm Health Care Sci, 2018, 4(14): 1-5. DOI: 10.1186/s40780-018-0111-5.

12.俞文桥. 糖皮质激素对重症急性胰腺炎致肾损伤的临床作用和机制[D]. 杭州: 浙江大学, 2019. DOI: 10.27461/d.cnki.gzjdx.2019.001201.

13.王晨, 张玫. 糖皮质激素用于急性重症胰腺炎疗效的系统评价[J]. 中国医院用药评价与分析, 2021, 21(1): 85-89. [Wang C, Zhang M. Systematic review of efficacy of glucocorticoids for severe acute pancreatitis[J]. Evaluation and Analysis of Drug-use in Hospitals of China, 2021, 21(1): 85-89.] DOI: 10.14009/j.issn.1672-2124. 2021.01.021.

14.Wang M, Jiang Z, Liang H. Glucocorticoids in acute pancreatitis: a propensity score matching analysis[J]. BMC Gastroenterol, 2021, 21(1): 331. DOI: 10.1186/s12876-021-01907-1.

15.Dong LH, Liu ZM, Wang SJ, et al. Corticosteroid therapy for severe acute pancreatitis: a meta-analysis of randomized, controlled trials[J]. Int J Clin Exp Pathol, 2015, 8(7): 7654-7660. https://pubmed.ncbi.nlm.nih.gov/26339332/.

16.中华医学会内分泌学分会, 中国内分泌代谢病专科联盟. 糖皮质激素类药物临床应用指导原则[J]. 中华内分泌代谢杂志, 2023, 39(4): 289-296. DOI: 10.3760/cma.j.cn311282-20230116-00029.

17.郭蒙蒙, 马茂源, 于小勇, 等. 短程大剂量甲泼尼龙辅治早期重症急性胰腺炎[J]. 南昌大学学报(医学版), 2016, 56(5): 70-72. [Guo MM, Ma MY, Yu XY, et al. Short term high-dose methylprednisolone adjuvant therapy for early severe acute pancreatitis[J]. Journal of Nanchang University (Medical Edition), 2016, 56(5): 70-72.] DOI: 10.13764/j.cnki.ncdm.2016.05.018.

18.Huh JW, Choi HS, Lim CM, et al. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days[J]. Respirology, 2011, 16(7): 1088-1095. DOI: 10.1111/j.1440-1843.2011.02018.x.

19.黄衔, 钟志旭, 陈明武, 等．早期小剂量甲泼尼龙治疗高脂血症性中度重症急性胰腺炎疗效观察[J]. 中华胰腺病杂志, 2017, 17(4): 267-269. [Huang X, Zhong ZX, Chen MW, et al. Observation of the therapeutic effect of early low-dose methylprednisolone in the treatment of moderate severe acute pancreatitis with hyperlipidemia[J]. Chinese Journal of Pancreatic Diseases, 2017, 17(4): 267-269.] DOI: 10.3760/cma.j.issn. 1674-1935.2017.04.015.

20.Lin W, Zheng Q, Wang X, et al. The causality between use of glucocorticoids and risk of pancreatitis: a Mendelian randomization study[J]. Front Immunol, 2024, 15: 1420840. DOI: 10.3389/fimmu.2024.1420840.